Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Subgroup Analyses: 30-Day End Points for Diabetic Patients by Treatment Group
The outcome data in subgroups, which are displayed as relative risk (RR) (solid squares) with 95% confidence interval (CI) (horizontal lines), are consistent with the data in the overall diabetic population for treatment with bivalirudin monotherapy versus heparin plus a glycoprotein IIb/IIIa inhibitor (GPI). CABG = coronary artery bypass graft; CKMB = creatine kinase isoenzyme MB fraction; CrCl = creatinine clearance; PCI = percutaneous coronary intervention.
|
